Hope Rugo
MD
Professor
👥Biography 个人简介
Hope Rugo at UCSF has contributed to breast cancer clinical research, including contributions to the ASCENT trial establishing sacituzumab govitecan (TROP-2 ADC) for relapsed/refractory TNBC — a major advance for this poor-prognosis breast cancer subtype. Her extensive contributions to breast cancer clinical trials across subtypes and her educational work have made her an influential figure in breast oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Hope Rugo 的研究动态
Follow Hope Rugo's research updates
留下邮箱，当我们发布与 Hope Rugo（UC San Francisco）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment